DNLI logo

Denali Therapeutics (DNLI) Depreciation and amortization

annual D&A:

$8.99M-$7.73M(-46.24%)
December 31, 2024

Summary

  • As of today (June 17, 2025), DNLI annual depreciation & amortization is $8.99 million, with the most recent change of -$7.73 million (-46.24%) on December 31, 2024.
  • During the last 3 years, DNLI annual D&A has risen by +$399.00 thousand (+4.64%).
  • DNLI annual D&A is now -46.24% below its all-time high of $16.73 million, reached on December 31, 2023.

Performance

DNLI Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

quarterly D&A:

$3.21M+$593.00K(+22.64%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI quarterly depreciation & amortization is $3.21 million, with the most recent change of +$593.00 thousand (+22.64%) on March 31, 2025.
  • Over the past year, DNLI quarterly D&A has increased by +$1.05 million (+48.57%).
  • DNLI quarterly D&A is now -68.03% below its all-time high of $10.05 million, reached on March 31, 2023.

Performance

DNLI quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

TTM D&A:

$10.04M+$1.05M(+11.68%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI TTM depreciation & amortization is $10.04 million, with the most recent change of +$1.05 million (+11.68%) on March 31, 2025.
  • Over the past year, DNLI TTM D&A has increased by +$1.20 million (+13.58%).
  • DNLI TTM D&A is now -46.13% below its all-time high of $18.64 million, reached on September 30, 2023.

Performance

DNLI TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIincome statement metrics

DNLI Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.2%+48.6%+13.6%
3 y3 years+4.6%+54.5%+17.3%
5 y5 years+12.5%+52.3%+30.5%

DNLI Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-46.2%+4.6%-68.0%+65.4%-46.1%+19.8%
5 y5-year-46.2%+12.5%-68.0%+65.4%-46.1%+30.5%
alltimeall time-46.2%+7331.4%-68.0%+339.4%-46.1%+1273.7%

DNLI Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.21M(+22.6%)
$10.04M(+11.7%)
Dec 2024
$8.99M(-46.2%)
$2.62M(+15.4%)
$8.99M(+5.2%)
Sep 2024
-
$2.27M(+16.8%)
$8.55M(+0.6%)
Jun 2024
-
$1.94M(-10.2%)
$8.50M(-3.9%)
Mar 2024
-
$2.16M(-0.7%)
$8.84M(-47.1%)
Dec 2023
$16.73M(+61.1%)
$2.18M(-1.8%)
$16.73M(-10.3%)
Sep 2023
-
$2.22M(-3.0%)
$18.64M(+0.4%)
Jun 2023
-
$2.29M(-77.3%)
$18.56M(+1.2%)
Mar 2023
-
$10.05M(+145.6%)
$18.35M(+76.7%)
Dec 2022
$10.38M(+20.8%)
$4.09M(+91.1%)
$10.38M(+23.8%)
Sep 2022
-
$2.14M(+3.3%)
$8.39M(-0.5%)
Jun 2022
-
$2.07M(-0.3%)
$8.43M(-1.5%)
Mar 2022
-
$2.08M(-0.7%)
$8.56M(-0.3%)
Dec 2021
$8.59M(+0.7%)
$2.09M(-4.3%)
$8.59M(-0.3%)
Sep 2021
-
$2.19M(-0.8%)
$8.62M(+0.4%)
Jun 2021
-
$2.20M(+4.6%)
$8.59M(+0.7%)
Mar 2021
-
$2.11M(-0.6%)
$8.53M(-0.0%)
DateAnnualQuarterlyTTM
Dec 2020
$8.53M(+6.8%)
$2.12M(-1.6%)
$8.53M(+0.8%)
Sep 2020
-
$2.16M(+0.5%)
$8.46M(+3.2%)
Jun 2020
-
$2.15M(+1.7%)
$8.20M(+6.5%)
Mar 2020
-
$2.11M(+2.6%)
$7.70M(-3.7%)
Dec 2019
$7.99M(+7.8%)
$2.06M(+8.7%)
$7.99M(-3.9%)
Sep 2019
-
$1.89M(+15.0%)
$8.31M(-5.0%)
Jun 2019
-
$1.64M(-31.6%)
$8.75M(-2.4%)
Mar 2019
-
$2.40M(+1.0%)
$8.96M(+20.9%)
Dec 2018
$7.42M(+140.6%)
$2.38M(+2.2%)
$7.42M(+26.9%)
Sep 2018
-
$2.33M(+25.4%)
$5.84M(+36.1%)
Jun 2018
-
$1.85M(+117.2%)
$4.29M(+34.0%)
Mar 2018
-
$854.00K(+5.8%)
$3.21M(+4.0%)
Dec 2017
$3.08M(+109.8%)
$807.00K(+3.7%)
$3.08M(+35.5%)
Sep 2017
-
$778.00K(+1.6%)
$2.27M(+52.0%)
Jun 2017
-
$766.00K(+4.8%)
$1.50M(+104.8%)
Mar 2017
-
$731.00K
$731.00K
Dec 2016
$1.47M(+1114.0%)
-
-
Dec 2015
$121.00K
-
-

FAQ

  • What is Denali Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Denali Therapeutics?
  • What is Denali Therapeutics annual D&A year-on-year change?
  • What is Denali Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Denali Therapeutics?
  • What is Denali Therapeutics quarterly D&A year-on-year change?
  • What is Denali Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Denali Therapeutics?
  • What is Denali Therapeutics TTM D&A year-on-year change?

What is Denali Therapeutics annual depreciation & amortization?

The current annual D&A of DNLI is $8.99M

What is the all time high annual D&A for Denali Therapeutics?

Denali Therapeutics all-time high annual depreciation & amortization is $16.73M

What is Denali Therapeutics annual D&A year-on-year change?

Over the past year, DNLI annual depreciation & amortization has changed by -$7.73M (-46.24%)

What is Denali Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of DNLI is $3.21M

What is the all time high quarterly D&A for Denali Therapeutics?

Denali Therapeutics all-time high quarterly depreciation & amortization is $10.05M

What is Denali Therapeutics quarterly D&A year-on-year change?

Over the past year, DNLI quarterly depreciation & amortization has changed by +$1.05M (+48.57%)

What is Denali Therapeutics TTM depreciation & amortization?

The current TTM D&A of DNLI is $10.04M

What is the all time high TTM D&A for Denali Therapeutics?

Denali Therapeutics all-time high TTM depreciation & amortization is $18.64M

What is Denali Therapeutics TTM D&A year-on-year change?

Over the past year, DNLI TTM depreciation & amortization has changed by +$1.20M (+13.58%)
On this page